Header Logo

Connection

MATTHEW JAMES to Adrenergic beta-Antagonists

Back to Details
This is a "connection" page, showing publications MATTHEW JAMES has written about Adrenergic beta-Antagonists.
MATTHEW JAMES
Connection Strength
0.026
Adrenergic beta-Antagonists
  1. Contrast-associated AKI and use of cardiovascular medications after acute coronary syndrome. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1840-8.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.